Viewing Study NCT05966558


Ignite Creation Date: 2025-12-25 @ 12:07 AM
Ignite Modification Date: 2025-12-25 @ 10:06 PM
Study NCT ID: NCT05966558
Status: UNKNOWN
Last Update Posted: 2023-07-28
First Post: 2021-01-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Cesarean Section Scar Niche: The Impact on Assisted Reproductive Technology Outcome
Sponsor: Zagazig University
Organization:

Study Overview

Official Title: Cesarean Section Scar Niche: The Impact on Assisted Reproductive Technology Outcome
Status: UNKNOWN
Status Verified Date: 2023-07
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: the presence of cesarean section niche has adverse effects on success of ART outcome
Detailed Description: A common finding by ultrasound in secondary infertility patients with previous cesarean sections is the presence of niche, which is formally defined as an indentation of the uterine myometrium of at least 2 mm at the site of the caesarean scar. The most common symptom of niche is abnormal uterine bleeding, other symptoms include dysmenorrhea, chronic pelvic pain, dyspareunia, and sub-fertility/infertility.

It has been reported that a niche can reduce the chances of embryo implantation and may lead to spontaneous miscarriages if the implantation is close to or in the niche. The presence of a niche may render the actual embryo transfer procedure technically more difficult, and clinicians need to be aware of its presence and perform the transfer under ultrasound guidance to ensure the catheter bypasses the niche and enters the uterine cavity. Still the impact of c.s niche and its characteristics on outcome of ART is not clear.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: